Dr. Sonali Mohanty Quantius
Founder, Haplomind
Sonali studied at IIT, Bombay, moved to Zurich where she received her PhD from University Hospital Zurich and then conducted postdoctoral research at ETH, Zurich. She then entered the pharmaceutical world by joining Eli Lily and the next 12 years saw her move to four countries (Singapore, USA, Sweden and the UK) and use computational biology in the domains of metabolic, genetics and now famous mRNA research. She is the founder of HAPLOMIND: a digital app that can screen and offer treatment for women experiencing depression and anxiety during pregnancy and postpartum. They are currently testing the app in a pilot study at NIMHANS, Bengaluru, India and plan to expand to the University Hospital Zürich in Switzerland. She is also working with researchers in Canada and New Zealand to make this digital solution available there.
Sonali studied at IIT, Bombay, moved to Zurich where she received her PhD from University Hospital Zurich and then conducted postdoctoral research at ETH, Zurich. She then entered the pharmaceutical world by joining Eli Lily and the next 12 years saw her move to four countries (Singapore, USA, Sweden and the UK) and use computational biology in the domains of metabolic, genetics and now famous mRNA research. She is the founder of HAPLOMIND: a digital app that can screen and offer treatment for women experiencing depression and anxiety during pregnancy and postpartum. They are currently testing the app in a pilot study at NIMHANS, Bengaluru, India and plan to expand to the University Hospital Zürich in Switzerland. She is also working with researchers in Canada and New Zealand to make this digital solution available there.
